Triple pill lowers risk of recurrent stroke by 39%
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
“Healthy” food labels increased consumer selections of healthier snacks and consumers were willing to pay a premium for such labeled products, according to new research. In 2024, the… read more.
Air pollution is associated with increased migraine activity, according to a study published on April 15, 2026, in Neurology®, the medical journal of the American Academy of Neurology. Both short-term… read more.
A routine component of many medical appointments—stepping on the scale to be weighed—may be a stigmatizing experience that raises patients’ blood pressure and potentially impacts their healthcare, according… read more.
People who take gabapentinoids, a medication prescribed increasingly frequently worldwide, particularly for chronic pain, face a much greater risk of drug poisoning if they are also taking another… read more.
Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have serious health challenges but have limited access to palliative… read more.
For years, a central debate in tobacco policy has been whether taxing e-cigarettes (ECs) might unintentionally drive vapers back to traditional cigarettes. A new study published in Health Economics suggests… read more.
Researchers presenting at the American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS26), taking place April 30th – May 2nd (pre-conference days Monday, April 27th – Wednesday, April 29th), represent the leading… read more.
Vertex Pharmaceuticals Incorporated announced the FDA has approved expanded use of Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a… read more.
Mutations in a key protein make a yeast found in dogs with common outer ear infections more resistant to the topical antifungals used to treat it, veterinarians and… read more.
Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment… read more.
One in four U.S. adults — the equivalent of over 66 million Americans — report having used artificial intelligence tools or chatbots for physical or mental healthcare information… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.